Jing ZENG

Featured in: Favicon

sciencedirect.com Favicon

biomedcentral.com Favicon

onlinelibrary.wiley.com Favicon

jcp.bmj.com Favicon

bmccancer.biomedcentral.com

Articles

Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy

Dec 9, 2024 | sciencedirect.com | Jing ZENG |Daniel Bauer |Wenbin Mei |Sohail F. Tavazoie

Patient tumor-derived organoids have been increasingly recognized as an essential tool for cancer research, providing a more accurate and physiological representation of patient tumors compared with cell line or xenograft models.1,2,3 While tumor organoids have been leveraged to study biological mechanisms of cancer4 and to generate diverse biobanks,1,5,6,7,8,9 they are now also emerging as a translationally useful platform for mirroring clinical responses to therapy, such as in breast,10,11...
Tunable Rh(III)-Catalyzed C(sp2)-H Bond Functionalization of Aryl Imidates with Cyclic 1,3-Diones: Strategic Use of Directing Groups | Organic Letters

Sep 6, 2024 | dx.doi.org | Luohe Wang |Jing ZENG |Hua Tian |Xiubin Bu

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →